Literature DB >> 26496888

Hematopoietic Stem Cells Therapies.

Mihaela Chivu-Economescu1, Martin Rubach2.   

Abstract

Stem cell-based therapies are recognized as a new way to treat various diseases and injuries, with a wide range of health benefits. The goal is to heal or replace diseased or destroyed organs or body parts with healthy new cells provided by stem cell transplantation. The current practical form of stem cell therapy is the hematopoietic stem cells transplant applied for the treatment of hematological disorders. There are over 2100 clinical studies in progress concerning hematopoietic stem cell therapies. All of them are using hematopoietic stem cells to treat various diseases like: cancers, leukemia, lymphoma, cardiac failure, neural disorders, auto-immune diseases, immunodeficiency, metabolic or genetic disorders. Several challenges are to be addressed prior to developing and applying large scale cell therapies: 1) to explain and control the mechanisms of differentiation and development toward a specific cell type needed to treat the disease, 2) to obtain a sufficient number of desired cell type for transplantation, 3) to overcome the immune rejection and 4) to show that transplanted cells fulfill their normal functions in vivo after transplants. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cell therapies; clinical applications; hematopoietic stem cells; transplant.

Mesh:

Year:  2017        PMID: 26496888     DOI: 10.2174/1574888X10666151026114241

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  9 in total

1.  Definitions for adult stem cells debated.

Authors:  Pura Muñoz-Cánoves; Meritxell Huch
Journal:  Nature       Date:  2018-11       Impact factor: 49.962

2.  Direct Differentiation of Human Primary Fibroblast into Hematopoietic-Like Stem Cells; A New Way without Viral Transduction.

Authors:  Sina Habibi; G Holamreza Khamisipour; Narges Obeidi; Saeedeh Zare Jaliseh
Journal:  Cell J       Date:  2020-07-18       Impact factor: 2.479

3.  Quantification of T Cell Binding Polyclonal Rabbit Anti-thymocyte Globulin in Human Plasma with Liquid Chromatography Tandem-Mass Spectrometry.

Authors:  Mohsin El Amrani; Rick Admiraal; Lobke Willaert; Lysette J C Ebskamp-van Raaij; Amelia M Lacna; C Erik Hack; Alwin D R Huitema; Stefan Nierkens; Erik M van Maarseveen
Journal:  AAPS J       Date:  2020-02-06       Impact factor: 4.009

Review 4.  Stem cell preservation for regenerative therapies: ethical and governance considerations for the health care sector.

Authors:  Zubin Master; Aidan P Crowley; Cambray Smith; Dennis Wigle; Andre Terzic; Richard R Sharp
Journal:  NPJ Regen Med       Date:  2020-12-01

5.  Stem cell therapy applied for digestive anastomosis: Current state and future perspectives.

Authors:  Jacobo Trébol; Tihomir Georgiev-Hristov; Isabel Pascual-Miguelañez; Hector Guadalajara; Mariano García-Arranz; Damian García-Olmo
Journal:  World J Stem Cells       Date:  2022-01-26       Impact factor: 5.326

6.  Levistilide A Promotes Expansion of Human Umbilical Cord Blood Hematopoietic Stem Cells by Enhancing Antioxidant Activity.

Authors:  Mei He; Hui Xu; Guangju Liu; Ming Yang; Wenshan Zhang; Yafang Li; Hexiao Zhang; Chaoqun Wang; Yiran Zhang; Xiaolei Liu; Shiqi Xu; Yahui Ding; Yinghui Li; Yingdai Gao; Quan Zhang
Journal:  Front Pharmacol       Date:  2022-02-17       Impact factor: 5.810

Review 7.  Stem cell therapy for faecal incontinence: Current state and future perspectives.

Authors:  Jacobo Trébol; Ana Carabias-Orgaz; Mariano García-Arranz; Damián García-Olmo
Journal:  World J Stem Cells       Date:  2018-07-26       Impact factor: 5.326

Review 8.  Hematopoietic Differentiation of Human Pluripotent Stem Cells: HOX and GATA Transcription Factors as Master Regulators.

Authors:  Khaled Alsayegh; Lorena V Cortés-Medina; Gerardo Ramos-Mandujano; Heba Badraiq; Mo Li
Journal:  Curr Genomics       Date:  2019-09       Impact factor: 2.236

9.  Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer.

Authors:  Ragima Nadesh; Krishnakumar N Menon; Lalitha Biswas; Ullas Mony; K Subramania Iyer; Sundeep Vijayaraghavan; Ajit Nambiar; Shantikumar Nair
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.